Effects of ligustrazine on the endothelin-1-induced myocardial hypertrophy

ZHU Xiao-ling,XIONG Li-ze,WANG Q,ZHU Xiao-xing,CHEN Ding-zhang,MENG Hua,Ma Xiao-tao
DOI: https://doi.org/10.3969/j.issn.1008-8199.2006.03.007
2006-01-01
Abstract:Objective: To investigate the action of tetramethylpyrazines on cardiac myocyte hypertrophy induced by endothelin-1(ET-1). Methods: The blockers of L-type calcium channel(Larcidipine),TMPP and TMPH were used to influence protein synthesis stimulated by chronic ET-1. Results:(ET-1) group's intracellular protein content in cardiac myocyte was(279±39)μg/ml(17% higher than the control group,P<0.05);ET-1+Larcidipine group was(231±43)μg/ml;(16.5% lower than the ET-1 group,P<0.05);ET-1+TMPP group was(236±36) μg/ml(13.5% lower than the ET-1 group,P<0.05);ET-1+TMPH group,(242±43) μg/ml(12.5% lower than the ET-1 group,P<0.05);Larcidipine,TMPP and TMPH inhibited ET-1-induced proliferation of cardiac fibroblasts. Conclusion: ET-1 induced growth-promoting in myocytes is associated with L-type calcium channels and effects of TMP maybe take place through blocking L-type calcium channels.
What problem does this paper attempt to address?